Global Arthropod-borne Viral Infection Testing Market Size, Trends & Growth Opportunity, By Test Type (Molecular Tests, Cultural Tests, Immunoassays, Others), By End User (Hospitals, Research Centers, Diagnostic Centers), By Region (North America, Europe, Asia Pacific, Latin America, Middle East) and forecast till 2030.

Report ID : AMR1004305 | Industries : Healthcare | Published On :December 2023 | Page Count : 228

Global Arthropod-borne Viral Infection Testing Market

The Arthropod-borne Viral Infection Testing Market was valued at USD 1.0 Billion in 2022 and is expected to expand to USD 1.9 Billion in 2030 at a CAGR of 8.35% during the forecast period 2023- 2030.

Market Overview

Arthropod-borne viral infections are caused by a group of viruses that are transmitted to humans by the bite of infected arthropods such as mosquitoes. These illnesses are also known as arboviral infections.

Market Drivers

The increased application of diagnostics to different illnesses is one of the main factors expected to accelerate the development and demand for testing for arthropod-borne viral infections. Furthermore, it is expected that the rapid rise of arboviruses, growing public health challenges, and integrated government activities would all contribute to the worldwide market's development over the projection period. Along with rising healthcare expenses, the prevalence of various arbovirus illnesses is predicted to rise, accelerating market expansion. Furthermore, the high population at risk for infections and the widespread distribution of arboviruses are expected to drive the development of the market for testing arthropod-borne viral diseases.

Market Restraints

Lack of in vitro facilities is the primary issue expected to impede the growth of the global market for testing for viral diseases transmitted by arthropods. Furthermore, a lack of awareness regarding diagnostic testing techniques and their restricted accessibility may impede market growth.

Impact of Covid-19

Governments and pharmaceutical and biotech businesses worldwide are collaborating to tackle the COVID-19 pandemic, ranging from facilitating vaccine development to addressing supply chain issues related to medications. There are now 155 compounds and about 115 vaccine candidates in the R&D pipeline. Additionally, there has been a significant increase in demand for regularly used medications such hydroxychloroquine for the treatment of COVID-19. Additionally, there has been a rise in the need for COVID-19 management medications, which is anticipated to present a business opportunity for pharmaceutical companies as many industrialised nations are experiencing a shortage of these medications.

Market Segmentation

Global Arthropod-borne Viral Infection Testing Market is segmented into Test Type and End User. By Test Type, the Global Arthropod-borne Viral Infection Testing Market is segmented into Molecular Tests, Cultural Tests, Immunoassays, Others. By End User, the Global Arthropod-borne Viral Infection Testing Market is segmented into Hospitals, Research Centers, Diagnostic Centers.

Regional Analysis

Global Arthropod-borne Viral Infection Testing Market is segmented into five regions such as North America, Europe, Latin America, Asia Pacific Middle East and Africa. Because of the rapid improvement of technology, the North America region leads the arthropod-borne viral diseases testing market. Because of the high population at risk of infection and the widespread distribution of arbovirus, Asia-Pacific is predicted to grow at a significant during the forecast period.

Market Key Players

Various key players are discussed in this report such Thermo Fisher Scientific, Inc., bioMerieux SA, Hologic, Inc., Fluke Biomedical, Datrend System, AESKU.GROUP, Achico, Agilent Technologies, Ahlborn, Bio-Rad, Copley Scientific, Acmas Technologie, and BioMed.

Market Taxonomy

By Test Type
• Molecular Tests
• Cultural Tests
• Immunoassays
• Others
By End User
• Hospitals
• Research Centers
• Diagnostic Centers
By Region
• North America
o U.S.
o Canada
o Mexico
• Latin America
o Brazil
o Argentina
o Colombia
o Peru
o Chile
o Venezuela
o Rest of Latin America
• Europe
o Germany
o France
o UK
o Russia
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o New Zealand
o Singapore
o Malaysia
o Rest of Asia Pacific
• Middle East & Africa
o Saudi Arabia
o UAE
o Egypt
o Kuwait
o South Africa
o Rest Middle East & Africa

Key Questions Addressed by the Report

• What are the Key Opportunities in Global Arthropod-borne Viral Infection Testing Market?
• What will be the growth rate from 2023 to 2030?
• Which segment/region will have highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
• What is the role of key players in the value chain?
• What are the strategies adopted by key players?

Global Arthropod-borne Viral Infection Testing Market

1 Introduction
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Arthropod-borne Viral Infection Testing Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to Recent Energy Crisis
4.2.5 Cumulative Impact due to Nearing Economic Downturn
4.2.6 Post Covid-19 World Supply & Demand Conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Arthropod-borne Viral Infection Testing Market, By Test Type
5.1 Y-o-Y Growth Comparison, By Test Type
5.2 Global Arthropod-borne Viral Infection Testing Market Share Analysis, By Test Type
5.3 Global Arthropod-borne Viral Infection Testing Market Size and Forecast, By Test Type
5.3.1 Molecular Tests
5.3.2 Cultural Tests
5.3.3 Immunoassays
5.3.4 Others
6 Global Arthropod-borne Viral Infection Testing Market, By End User
6.1 Y-o-Y Growth Comparison, By End User
6.2 Global Arthropod-borne Viral Infection Testing Market Share Analysis, By End User
6.3 Global Arthropod-borne Viral Infection Testing Market Size and Forecast, By End User
6.3.1 Hospitals
6.3.2 Research Centers
6.3.3 Diagnostic Centers
7 Global Arthropod-borne Viral Infection Testing Market, By Region
7.1 Global Arthropod-borne Viral Infection Testing Market Share Analysis, By Region
7.2 Global Arthropod-borne Viral Infection Testing Market Size and Forecast, By Region
7.3 Global Arthropod-borne Viral Infection Testing Market Trends and Forecast, By Region
8 North America Arthropod-borne Viral Infection Testing Market Analysis and Forecast (2023-2030)
8.1 Introduction
8.2 North America Arthropod-borne Viral Infection Testing Market Size and Forecast, By Test Type
8.3 North America Arthropod-borne Viral Infection Testing Market Size and Forecast, By End User
8.4 North America Arthropod-borne Viral Infection Testing Market Size and Forecast, By Country
8.4.1 U.S.
8.4.1.1 Market Size and Forecast, By Test Type
8.4.1.2 Market Size and Forecast, By End User
8.4.2 Canada
8.4.2.1 Market Size and Forecast, By Test Type
8.4.2.2 Market Size and Forecast, By End User
8.4.3 Mexico
8.4.3.1 Market Size and Forecast, By Test Type
8.4.3.2 Market Size and Forecast, By End User
9 Europe Arthropod-borne Viral Infection Testing Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 Europe Arthropod-borne Viral Infection Testing Market Size and Forecast, By Test Type
9.3 Europe Arthropod-borne Viral Infection Testing Market Size and Forecast, By End User
9.4 Europe Arthropod-borne Viral Infection Testing Market Size and Forecast, By Country
9.4.1 Germany
9.4.1.1 Market Size and Forecast, By Test Type
9.4.1.2 Market Size and Forecast, By End User
9.4.2 France
9.4.2.1 Market Size and Forecast, By Test Type
9.4.2.2 Market Size and Forecast, By End User
9.4.3 UK
9.4.3.1 Market Size and Forecast, By Test Type
9.4.3.2 Market Size and Forecast, By End User
9.4.4 Russia
9.4.4.1 Market Size and Forecast, By Test Type
9.4.4.2 Market Size and Forecast, By End User
9.4.5 Italy
9.4.5.1 Market Size and Forecast, By Test Type
9.4.5.2 Market Size and Forecast, By End User
9.4.6 Spain
9.4.6.1 Market Size and Forecast, By Test Type
9.4.6.2 Market Size and Forecast, By End User
9.4.7 Rest of Europe
9.4.7.1 Market Size and Forecast, By Test Type
9.4.7.2 Market Size and Forecast, By End User
10 Asia Pacific Arthropod-borne Viral Infection Testing Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Asia Pacific Arthropod-borne Viral Infection Testing Market Size and Forecast, By Test Type
10.3 Asia Pacific Arthropod-borne Viral Infection Testing Market Size and Forecast, By End User
10.4 Asia Pacific Arthropod-borne Viral Infection Testing Market Size and Forecast, By Country
10.4.1 China
10.4.1.1 Market Size and Forecast, By Test Type
10.4.1.2 Market Size and Forecast, By End User
10.4.2 Japan
10.4.2.1 Market Size and Forecast, By Test Type
10.4.2.2 Market Size and Forecast, By End User
10.4.3 India
10.4.3.1 Market Size and Forecast, By Test Type
10.4.3.2 Market Size and Forecast, By End User
10.4.4 South Korea
10.4.4.1 Market Size and Forecast, By Test Type
10.4.4.2 Market Size and Forecast, By End User
10.4.5 Australia
10.4.5.1 Market Size and Forecast, By Test Type
10.4.5.2 Market Size and Forecast, By End User
10.4.6 New Zealand
10.4.6.1 Market Size and Forecast, By Test Type
10.4.6.2 Market Size and Forecast, By End User
10.4.7 Singapore
10.4.7.1 Market Size and Forecast, By Test Type
10.4.7.2 Market Size and Forecast, By End User
10.4.8 Malaysia
10.4.8.1 Market Size and Forecast, By Test Type
10.4.8.2 Market Size and Forecast, By End User
10.4.9 Rest of Asia
10.4.9.1 Market Size and Forecast, By Test Type
10.4.9.2 Market Size and Forecast, By End User
11 Latin America Arthropod-borne Viral Infection Testing Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Latin America Arthropod-borne Viral Infection Testing Market Size and Forecast, By Test Type
11.3 Latin America Arthropod-borne Viral Infection Testing Market Size and Forecast, By End User
11.4 Latin America Arthropod-borne Viral Infection Testing Market Size and Forecast, By Country
11.4.1 Brazil
11.4.1.1 Market Size and Forecast, By Test Type
11.4.1.2 Market Size and Forecast, By End User
11.4.2 Argentina
11.4.2.1 Market Size and Forecast, By Test Type
11.4.2.2 Market Size and Forecast, By End User
11.4.3 Colombia
11.4.3.1 Market Size and Forecast, By Test Type
11.4.3.2 Market Size and Forecast, By End User
11.4.4 Peru
11.4.4.1 Market Size and Forecast, By Test Type
11.4.4.2 Market Size and Forecast, By End User
11.4.5 Chile
11.4.5.1 Market Size and Forecast, By Test Type
11.4.5.2 Market Size and Forecast, By End User
11.4.6 Venezuela
11.4.6.1 Market Size and Forecast, By Test Type
11.4.6.2 Market Size and Forecast, By End User
11.4.7 Rest of Latin America
11.4.7.1 Market Size and Forecast, By Test Type
11.4.7.2 Market Size and Forecast, By End User
12 Middle East Arthropod-borne Viral Infection Testing Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Middle East Arthropod-borne Viral Infection Testing Market Size and Forecast, By Test Type
12.3 Middle East Arthropod-borne Viral Infection Testing Market Size and Forecast, By End User
12.4 Middle East Arthropod-borne Viral Infection Testing Market Size and Forecast, By Country
12.4.1 Saudi Arabia
12.4.1.1 Market Size and Forecast, By Test Type
12.4.1.2 Market Size and Forecast, By End User
12.4.2 UAE
12.4.2.1 Market Size and Forecast, By Test Type
12.4.2.2 Market Size and Forecast, By End User
12.4.3 Egypt
12.4.3.1 Market Size and Forecast, By Test Type
12.4.3.2 Market Size and Forecast, By End User
12.4.4 Kuwait
12.4.4.1 Market Size and Forecast, By Test Type
12.4.4.2 Market Size and Forecast, By End User
12.4.5 South Africa
12.4.5.1 Market Size and Forecast, By Test Type
12.4.5.2 Market Size and Forecast, By End User
12.4.6 Rest of Middle East & Africa
12.4.6.1 Market Size and Forecast, By Test Type
12.4.6.2 Market Size and Forecast, By End User
13 Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14 Company Profiles
14.1 Thermo Fisher Scientific, Inc.
14.1.2 Offerings
14.1.3 Key Financials
14.1.4 Business Segment & Geographic Overview
14.1.5 Key Market Developments
14.1.6 Key Strategies
14.2 bioMerieux SA
14.2.1 Overview
14.2.2 Offerings
14.2.3 Key Financials
14.2.4 Business Segment & Geographic Overview
14.2.5 Key Market Developments
14.2.6 Key Strategies
14.3 Hologic, Inc.
14.3.1 Overview
14.3.2 Offerings
14.3.3 Key Financials
14.3.4 Business Segment & Geographic Overview
14.3.5 Key Market Developments
14.3.6 Key Strategies
14.4 Fluke Biomedical
14.4.1 Overview
14.4.1 Overview
14.4.2 Offerings
14.4.3 Key Financials
14.4.4 Business Segment & Geographic Overview
14.4.5 Key Market Developments
14.4.6 Key Strategies
14.5 Datrend System
14.5.1 Overview
14.5.2 Offerings
14.5.3 Key Financials
14.5.4 Business Segment & Geographic Overview
14.5.5 Key Market Developments
14.5.6 Key Strategies
14.6 AESKU.GROUP
14.6.1 Overview
14.6.2 Offerings
14.6.3 Key Financials
14.6.4 Business Segment & Geographic Overview
14.6.5 Key Market Developments
14.6.6 Key Strategies
14.7 Achico
14.7.1 Overview
14.7.2 Offerings
14.7.3 Key Financials
14.7.4 Business Segment & Geographic Overview
14.7.5 Key Market Developments
14.7.6 Key Strategies
14.8 Agilent Technologies
14.8.1 Overview
14.8.2 Offerings
14.8.3 Key Financials
14.8.4 Business Segment & Geographic Overview
14.8.5 Key Market Developments
14.8.6 Key Strategies
14.9 Acmas Technologie
14.9.1 Overview
14.9.2 Offerings
14.9.3 Key Financials
14.9.4 Business Segment & Geographic Overview
14.9.5 Key Market Developments
14.9.6 Key Strategies
14.10 BioMed
14.10.1 Overview
14.10.2 Offerings
14.10.3 Key Financials
14.10.4 Business Segment & Geographic Overview
14.10.5 Key Market Developments
14.10.6 Key Strategies